InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,433.74
(
0.23%
)
US TECH 100
19,068.80
(
0.00%
)
Dow Jones
38,647.10
(
-0.17%
)
Brent Oil
82.20
(
0.27%
)
Bitcoin
66,937.58
(
0.27%
)
Post# of 21373
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ninersax

Send PM Follow Ignore
Followers 6
Posts 488
Boards Moderated 0
Alias Born 01/17/2017

ninersax

Re: nonewname1 post# 1331

Friday, 03/17/2017 2:01:37 PM

Friday, March 17, 2017 2:01:37 PM

Post# of 21373
I can't seem to think of a single reason why they would takeover a shell to go public if the drug did poorly in the trials. In fact, it suggests just the opposite to me.

It takes money to go through clinical trials. They are definitely looking for financing and going public is a great way to finance their operations. This is a perfect shell for them to do it with too. Low SS and no debt.

Never mention R/S. There's no reason to mention that. To even fathom that is absurd. The OS is 33 million. That is entirely too small for that to ever be a consideration.

My posts are of my opinion and should not be taken as solid trading advice. I do not have a vision of the future. I follow trends and base my decisions on that alone.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up